Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.

Kotoe TakayoshiHitoshi KusabaTomomi AikawaSakuya KoreishiKosuke SagaraMichitaka NakanoMasato KomodaMihoko KonoMitsuhiro FukataTakeshi AritaTaito EsakiKoichi AkashiEishi Baba

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2019)

Hypoalbuminemia appears to be a risk factor for AGC-associated VTE. DOACs are effective to AGC-associated VTE, but careful observation of bleeding events is required.

Keyphrases

venous thromboembolism
direct oral anticoagulants
atrial fibrillation
small cell lung cancer
squamous cell carcinoma
combination therapy
replacement therapy
smoking cessation